Annual Report Reveals Material Weaknesses in Internal Controls Amidst Strong Revenue Growth and Strategic Expansion

summarizeSummary

The 2025 annual report shows strong revenue growth and strategic expansion, including major contracts and government funding, but is significantly impacted by the disclosure of material weaknesses in internal controls over financial reporting.

check_boxKey Events

• Material Weaknesses in Internal Controls Identified

  Management concluded that internal control over financial reporting was not effective as of December 31, 2025, due to material weaknesses in design, documentation, monitoring, absence of proper segregation of duties, and potential for management override.

• Significant Revenue Growth

  Revenues increased by 163% to $39.3 million in 2025, primarily driven by a 230% increase in the average antimony sales price per pound.

• Substantial Capital Raises

  The company raised $110 million in net proceeds during 2025 through at-the-market offerings and registered direct offerings, plus $5.7 million from warrant exercises. An additional $1.4 million was raised in March 2026.

• Major Contracts and Government Funding Secured

  A five-year, sole-source IDIQ contract with the U.S. Defense Logistics Agency for up to $248 million was secured in September 2025, along with a new five-year industrial sales agreement. The company was also awarded $27.0 million by the U.S. Department of War in March 2026 for production capabilities.

auto_awesomeAnalysis

United States Antimony Corporation's annual report for 2025 highlights significant operational growth and strategic advancements, including a 163% increase in revenues to $39.3 million, driven by higher antimony prices. The company secured a substantial $248 million DLA contract and a new industrial sales agreement, alongside a $27 million government funding award for production expansion. It also raised $110 million in capital during 2025 and entered a key joint venture for a new processing facility. However, these positives are significantly overshadowed by the disclosure of material weaknesses in internal control over financial reporting as of December 31, 2025. This indicates a high risk of financial misstatement and regulatory non-compliance, which is a critical concern for investors. The company also reported an increased net loss and negative cash flow from operations, and faces substantial potential dilution if all authorized shares were issued.